GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹230 Cr | ₹132 Cr | ₹68 Cr | ₹59 Cr | ₹57 Cr |
What is the latest Total Liabilities ratio of GENNEX LABORATORIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹230 Cr |
Mar2023 | ₹132 Cr |
Mar2022 | ₹68 Cr |
Mar2021 | ₹59 Cr |
Mar2020 | ₹57 Cr |
How is Total Liabilities of GENNEX LABORATORIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹230 Cr | 73.82 | |
Mar2023 | ₹132 Cr | 94.30 | |
Mar2022 | ₹68 Cr | 15.49 | |
Mar2021 | ₹59 Cr | 3.44 | |
Mar2020 | ₹57 Cr | - |
Compare Total Liabilities of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹434.1 Cr | 1.1% | -7.3% | 19.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,544.0 Cr | 2.8% | -2.7% | 50.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,865.0 Cr | 3.5% | 5.4% | 67.6% | Stock Analytics | |
CIPLA | ₹123,920.0 Cr | 2.9% | -1.2% | 25.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,224.0 Cr | 2.1% | -3.9% | 6.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,832.3 Cr | 3.3% | -2% | 53.5% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | 1.1% |
-7.3% |
19.2% |
SENSEX | 1.1% |
1.1% |
22.2% |
You may also like the below Video Courses